Stenobird

Episode

The First AI Designed Drugs Are in the Clinic: 200 Candidates, Zero Approvals, and the Race to the First FDA Win - June 4, 2026

Podcast
DX Today | No-Hype Podcast & News About AI & DX
Published
Jun 4, 2026
Duration seconds
722
Processing state
not_requested
Canonical source
https://www.buzzsprout.com/2207817/episodes/19292587-the-first-ai-designed-drugs-are-in-the-clinic-200-candidates-zero-approvals-and-the-race-to-the-first-fda-win-june-4-2026.mp3
Audio
https://www.buzzsprout.com/2207817/episodes/19292587-the-first-ai-designed-drugs-are-in-the-clinic-200-candidates-zero-approvals-and-the-race-to-the-first-fda-win-june-4-2026.mp3
JSON
/v1/public/podcasts/dx-today-no-hype-podcast-news-about-ai-dx-6434212/episodes/the-first-ai-designed-drugs-are-in-the-clinic-200-candidates-zero-approvals-and-the-race-to-the-first-fda-win-june-4-2026
Markdown
/podcast/dx-today-no-hype-podcast-news-about-ai-dx-6434212/the-first-ai-designed-drugs-are-in-the-clinic-200-candidates-zero-approvals-and-the-race-to-the-first-fda-win-june-4-2026.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/dx-today-no-hype-podcast-news-about-ai-dx-6434212/episodes/the-first-ai-designed-drugs-are-in-the-clinic-200-candidates-zero-approvals-and-the-race-to-the-first-fda-win-june-4-2026/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/dx-today-no-hype-podcast-news-about-ai-dx-6434212/the-first-ai-designed-drugs-are-in-the-clinic-200-candidates-zero-approvals-and-the-race-to-the-first-fda-win-june-4-2026.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Send us Fan Mail The First AI Designed Drugs Are in the Clinic: 200 Candidates, Zero Approvals, and the Race to the First FDA Win - June 4, 2026 More than 200 AI discovered drug candidates are now in human trials, yet not one has been approved. We dig into Insilico Medicine's Rentosertib, Relay Therapeutics' Zovegalisib, Eli Lilly's 2.75 billion dollar Insilico deal, and the LillyPod supercomputer to ask whether 2026 through 2028 is the make or break window for the first FDA approval of an A...